These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2824926)

  • 1. Experience with a sulfonamide diuretic in a large urine drug testing program.
    Podkowik BI; Smith ML; Pick RO
    J Anal Toxicol; 1987; 11(5):215-8. PubMed ID: 2824926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-phase extraction of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid from urine drug-testing specimens with the cerex polycrom-THC column.
    Crockett DK; Nelson G; Dimson P; Urry FM
    J Anal Toxicol; 2000; 24(4):245-9. PubMed ID: 10872570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid method for the GC/MS confirmation of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in urine.
    Baker TS; Harry JV; Russell JW; Myers RL
    J Anal Toxicol; 1984; 8(6):255-9. PubMed ID: 6097767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of past and recurrent marijuana use by a modified GC/MS procedure.
    Joern WA
    J Anal Toxicol; 1987; 11(2):49-52. PubMed ID: 3033397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-phase extraction of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid from human urine with gas chromatographic-mass spectrometric confirmation.
    Dixit V; Dixit VM
    J Chromatogr; 1991 Jun; 567(1):81-91. PubMed ID: 1655822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of 11-nor-delta 9-tetrahydrocannabinol in urine as its t-butyldimethylsilyl derivative using GC/MS.
    Clouette R; Jacob M; Koteel P; Spain M
    J Anal Toxicol; 1993; 17(1):1-4. PubMed ID: 8381495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantitation of urinary 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid, a metabolite of tetrahydrocannabinol, by capillary gas chromatography and electron impact mass fragmentography.
    Paul BD; Mell LD; Mitchell JM; McKinley RM; Irving J
    J Anal Toxicol; 1987; 11(1):1-5. PubMed ID: 3029505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False negative GC/MS assay for carboxy THC due to ibuprofen interference.
    Brunk SD
    J Anal Toxicol; 1988; 12(5):290-1. PubMed ID: 2852278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of THCA in oral fluid by GC-MS-MS.
    Day D; Kuntz DJ; Feldman M; Presley L
    J Anal Toxicol; 2006; 30(9):645-50. PubMed ID: 17137523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemp oil ingestion causes positive urine tests for delta 9-tetrahydrocannabinol carboxylic acid.
    Costantino A; Schwartz RH; Kaplan P
    J Anal Toxicol; 1997 Oct; 21(6):482-5. PubMed ID: 9323529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of a tetrahydrocannabinol metabolite in urine by gas chromatography.
    Whiting JD; Manders WW
    J Anal Toxicol; 1982; 6(1):49-52. PubMed ID: 6281576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a rapid semi-automated sample preparation with alkaline hydrolysis in a 96-well plate for quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in urine samples by UHPLC-MS/MS.
    Müller LD; Opdal MS
    J Pharm Biomed Anal; 2018 Nov; 161():296-304. PubMed ID: 30189411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas chromatography-mass spectrometry-single ion monitoring measurement of 11-nor-delta 9-tetrahydrocannabinol-carboxylic acid in urine.
    Boldis O; Kocsis G; Gachályi A; Furész J
    J Chromatogr Sci; 2003 Apr; 41(4):190-4. PubMed ID: 12803806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Routine detection of the THC metabolite 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in forensic practice].
    Hanke M; Megges G
    Z Rechtsmed; 1983; 90(2):105-8. PubMed ID: 6312709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of EMIT and RIA high volume test procedures for THC metabolites in urine utilizing GC/MS confirmation.
    Abercrombie ML; Jewell JS
    J Anal Toxicol; 1986; 10(5):178-80. PubMed ID: 3022068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel fast method for aqueous derivatization of THC, OH-THC and THC-COOH in human whole blood and urine samples for routine forensic analyses.
    Stefanelli F; Pesci FG; Giusiani M; Chericoni S
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29135039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference in GC/MS confirmation of delta-9-tetrahydrocannabinol-9-carboxylic acid by a secondary tetrahydrocannabinol metabolite.
    Podkowik BI; Kippenberger DJ; Smith ML
    Clin Chem; 1991 Jul; 37(7):1307-8. PubMed ID: 1649710
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection of the metabolite of delta-9-tetrahydrocannabinol in urine by means of GC/MS and interpretation of analytical findings].
    Balíková M; Maresová V
    Soud Lek; 1996 Dec; 41(4):36-40. PubMed ID: 16841441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 11-Nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine by ion trap GC-MS-MS in the context of doping analysis.
    Caballero GM; D'Angelo C; Fraguío MS; Centurión OT
    J Chromatogr Sci; 2004; 42(10):540-4. PubMed ID: 15768841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques.
    Jung J; Meyer MR; Maurer HH; Neusüss C; Weinmann W; Auwärter V
    J Mass Spectrom; 2009 Oct; 44(10):1423-33. PubMed ID: 19728318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.